Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark I Greene

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2003
Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivationToru Kumagai, Makoto Katsumata, Akihiro Hasegawa, et al.
Current Opinion in Immunology|August 21, 2007
Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppressionBin Li, Sandra J Saouaf, Arabinda Samanta, et al.
Cellular & Molecular Immunology|September 11, 2012
Germinal center kinases in immune regulationHailei Yin, Zhubing Shi, Shi Jiao, et al.
Seminars in Cell & Developmental Biology|September 21, 2010
Targeting erbB receptorsZheng Cai, Hongtao Zhang, Jing Liu, et al.
Molecular Biology of the Cell|October 14, 2005
UXT is a novel centrosomal protein essential for cell viabilityHuiwu Zhao, Qiang Wang, Hongtao Zhang, et al.
The Journal of Clinical Investigation|August 3, 2007
ErbB receptors: from oncogenes to targeted cancer therapiesHongtao Zhang, Alan Berezov, Qiang Wang, et al.
Experimental and Molecular Pathology|October 9, 2012
Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cellsGuoping Deng, Yan Xiao, Zhaocai Zhou, et al.
Oncoimmunology|April 11, 2018
A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γHongtao Zhang, Lian Lam, Yasuhiro Nagai, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agentDatta E Ponde, ZiFen Su, Alan Berezov, et al.
Oncotarget|February 10, 2018
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77Xi Chen, Yasuhiro Nagai, Zhiqiang Zhu, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2003
Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivationToru Kumagai, Makoto Katsumata, Akihiro Hasegawa, et al.
Current Opinion in Immunology|August 21, 2007
Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppressionBin Li, Sandra J Saouaf, Arabinda Samanta, et al.
Cellular & Molecular Immunology|September 11, 2012
Germinal center kinases in immune regulationHailei Yin, Zhubing Shi, Shi Jiao, et al.
Seminars in Cell & Developmental Biology|September 21, 2010
Targeting erbB receptorsZheng Cai, Hongtao Zhang, Jing Liu, et al.
Molecular Biology of the Cell|October 14, 2005
UXT is a novel centrosomal protein essential for cell viabilityHuiwu Zhao, Qiang Wang, Hongtao Zhang, et al.
The Journal of Clinical Investigation|August 3, 2007
ErbB receptors: from oncogenes to targeted cancer therapiesHongtao Zhang, Alan Berezov, Qiang Wang, et al.
Experimental and Molecular Pathology|October 9, 2012
Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cellsGuoping Deng, Yan Xiao, Zhaocai Zhou, et al.
Oncoimmunology|April 11, 2018
A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γHongtao Zhang, Lian Lam, Yasuhiro Nagai, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2011
Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agentDatta E Ponde, ZiFen Su, Alan Berezov, et al.
Oncotarget|February 10, 2018
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77Xi Chen, Yasuhiro Nagai, Zhiqiang Zhu, et al.
Pageof 12